Clinical trials
Recruiting Phase 1 Myositis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2024 | 5 |
| 2025 | 15 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China Immunotech (Beijing) Biotechnology Co., Ltd. | 5 |
| AstraZeneca | 2 |
| Tongji Hospital | 2 |
| Allogene Therapeutics | 1 |
| Austin Neuromuscular Center | 1 |
| Beijing GoBroad Hospital | 1 |
| CRISPR Therapeutics | 1 |
| CytoCares Inc | 1 |
| Daishi Tian | 1 |
| Fate Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myositis | 28 |
| Lupus Erythematosus, Systemic | 20 |
| Scleroderma, Systemic | 16 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 10 |
| Autoimmune Diseases | 9 |
| Arthritis, Rheumatoid | 7 |
| Lupus Nephritis | 7 |
| Sjogren's Syndrome | 7 |
| Antiphospholipid Syndrome | 6 |
| Dermatomyositis | 4 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.